HOUSTON, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE: IBO), is thrilled to announce a significant milestone in its innovative Linebacker™ technology platform. The Canadian...
HOUSTON, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting innovative...
HOUSTON, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (“IBO”) is pleased to announce that the US Patent and Trademark Office has issued U.S. Patent No. 11,985,973 entitled “Insect...
NEW YORK, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting unique healthcare...
NEW YORK, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a company discovering and developing new offerings in human healthcare and wellness, today announced...
NEW YORK, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a company discovering and developing new offerings in human healthcare and wellness today announced the...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.19 | 6.78571428571 | 2.8 | 3.2 | 2.49 | 55912 | 2.78003816 | CS |
4 | 1.54 | 106.206896552 | 1.45 | 3.2 | 1.22 | 63903 | 2.25473935 | CS |
12 | -0.01 | -0.333333333333 | 3 | 3.2 | 1.22 | 97054 | 2.225476 | CS |
26 | -0.01 | -0.333333333333 | 3 | 3.2 | 1.22 | 97054 | 2.225476 | CS |
52 | -0.01 | -0.333333333333 | 3 | 3.2 | 1.22 | 97054 | 2.225476 | CS |
156 | -0.01 | -0.333333333333 | 3 | 3.2 | 1.22 | 97054 | 2.225476 | CS |
260 | -0.01 | -0.333333333333 | 3 | 3.2 | 1.22 | 97054 | 2.225476 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約